Qiagen
Company Snapshot
Company Overview
QIAGEN was founded in 1984 and is headquartered in Venlo, Netherlands. It is a major player in molecular diagnostics, life sciences research, and applied testing. The company operates through two segments: molecular diagnostics and life sciences. The company focuses on technologies that help extract, purify, and analyze genetic materials like DNA, RNA, and proteins. QIAGEN serves various industries, including academic research, clinical diagnostics, pharmaceutical development, forensics, and agriculture, and it has a diverse range of products. Its core strengths lie in sample preparation, molecular diagnostics, and bioinformatics, supporting advances in personalized medicine, infectious disease detection, cancer genomics, and oncology diagnostics.
QIAGEN is a parent company with more than 50 consolidated subsidiaries, many of which are primarily responsible for the regional distribution of its products and services.
Financial Highlights (FY 2023)
This information is available for BCC Research members only.
Qiagen In News
Company's Business Segments
- Molecular diagnostics : Molecular testing, Oncology, Infectous diseases and Immune Monitoring
- Life Sciences : Medicine and clinical development, frorensics, exploring the building blocks of life.
Applications/End User Industries
- Real-Time PCR Instrumentation
- Nucleic Acid Amplification
- Automated Systems
- Automated Sample Preparation
- High-Throughput Testing
- Point-of-Care Diagnostic Systems
- Rapid Testing
- Clinical Settings
- Next-Generation Sequencing (NGS)
- Automated Liquid Handling
- Oncology
- Infectious Diseases
- Molecular Pathology
- Tissue Extraction Kits
- Tissue-Based Diagnostics
- Life Sciences Research
- Genomics
- Transcriptomics
- Proteomics
- High-Throughput DNA Sequencing
